1. Home
  2. SWBI vs IRWD Comparison

SWBI vs IRWD Comparison

Compare SWBI & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SWBI

Smith & Wesson Brands Inc.

HOLD

Current Price

$15.01

Market Cap

651.8M

Sector

Industrials

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.85

Market Cap

658.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWBI
IRWD
Founded
1852
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Ordnance And Accessories
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
651.8M
658.5M
IPO Year
2000
2009

Fundamental Metrics

Financial Performance
Metric
SWBI
IRWD
Price
$15.01
$3.85
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
$14.00
$7.67
AVG Volume (30 Days)
1.0M
2.7M
Earning Date
06-17-2026
05-11-2026
Dividend Yield
3.37%
N/A
EPS Growth
36.67
1400.00
EPS
0.41
0.24
Revenue
$523,845,000.00
$298,276,000.00
Revenue This Year
$7.61
$57.95
Revenue Next Year
$3.72
$4.39
P/E Ratio
$36.24
$16.15
Revenue Growth
10.36
8.88
52 Week Low
$7.73
$0.72
52 Week High
$17.56
$5.78

Technical Indicators

Market Signals
Indicator
SWBI
IRWD
Relative Strength Index (RSI) 46.37 44.78
Support Level $13.83 $3.80
Resistance Level $15.24 $3.95
Average True Range (ATR) 0.47 0.22
MACD -0.07 -0.07
Stochastic Oscillator 13.28 5.64

Price Performance

Historical Comparison
SWBI
IRWD

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: